Land: Australien
Sprache: Englisch
Quelle: Department of Health (Therapeutic Goods Administration)
ranitidine hydrochloride
Amneal Pharma Australia Pty Ltd
Ranitidine hydrochloride
Registered
_Ranitidine AN tablets – Consumer Medicine Information _ _ _ _Doc ID: 95.AN.M.1.0 _ _ _ _ _ _Page 1 _ RANITIDINE AN TABLETS _Ranitidine hydrochloride tablets _ CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some common questions about Ranitidine AN. It does not contain all of the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have benefits and risks. Your doctor has weighed the risks of you taking Ranitidine AN against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, TALK TO YOUR DOCTOR OR PHARMACIST. Keep this leaflet with your medicine. You may need to read it again. WHAT RANITIDINE AN IS USED FOR The name of your medicine is Ranitidine AN. It contains the active ingredient ranitidine hydrochloride. It belongs to a group of medicines called H 2 -antagonists or H2-blockers. Ranitidine works by reducing the amount of acid produced by your stomach. Ranitidine is used for the following: To treat and prevent peptic ulcers. Peptic ulcers are ulcers that occur in the stomach or duodenum. To treat reflux or heartburn Zollinger-Ellison Syndrome Scleroderma oesophagitis By reducing the amount of acid produced by the stomach, Ranitidine AN reduces the pain associated with the above conditions, helps ulcers to heal and helps heal oesphagitis. Your doctor may have prescribed Ranitidine AN for another reason. Ask your doctor if you have any questions about why Ranitidine AN has been prescribed for you. Ranitidine AN is available only with a doctor’s prescription. Ranitidine AN is not addictive. BEFORE YOU TAKE RANITIDINE AN _WHEN YOU MUST NOT TAKE _ _IT _ DO NOT TAKE RANITIDINE AN IF YOU HAVE AN ALLERGY TO RANITIDINE OR ANY OF THE INGREDIENTS LISTED AT THE END OF THIS LEAFLET. Symptoms of an allergic reaction may include asthma, wheezing, shortness of breath, swelling of the face, lips or tongue which may cause difficulty in swallowing or breathing, hives, itching or ski Lesen Sie das vollständige Dokument
_Ranitidine AN tablets Product Information _ _ Amneal Pharma Australia Pty Ltd _ Ranitidine AN PI v2.0 Page 1 RANITIDINE AN _ _ _(RANITIDINE (AS HYDROCHLORIDE) TABLETS) _ _ _ PRODUCT INFORMATION NAME OF THE MEDICINE The name of the medicine is ranitidine hydrochloride CHEMICAL NAME: _N_-[2-[[[5-[(dimethylamino)methyl]furan-2-yl]methyl]-thio]ethyl]-_N’-_ methyl-2-nitroethene-1,1-diamine hydrochloride MOLECULAR FORMULA: C 13 H 22 N 4 O 3 S.HCl MOLECULAR WEIGHT: 350.87 CAS REGISTRY NUMBER: _[66357-59-3] _ DESCRIPTION Ranitidine hydrochloride is an aminoalkyl substituted furan and is structurally different from cimetidine, lacking the imidazole ring and the cyanoguanidine group. Each Ranitidine AN tablet contains ranitidine hydrochloride equivalent to 150 mg or 300 mg of ranitidine respectively. Each tablet also contains the following excipients: microcrystalline cellulose, croscarmellose sodium, colloidal anhydrous silica, purified talc, purified water, magnesium stearate, hypromellose, castor oil, iron oxide yellow, titanium dioxide, OPACODE monogramming ink S-1-27794 BLACK. PHARMACOLOGY Ranitidine hydrochloride is a histamine H 2 -receptor antagonist. Animal experiments both _ in vitro _ and _ in vivo _ have established that ranitidine is a selective, competitive antagonist of histamine at H 2 -receptor sites. Ranitidine has no significant interaction at histamine H 1 -receptors, muscarinic receptors or β-adrenoceptors. Ranitidine is a potent inhibitor of gastric secretion in the rat and dog. All the evidence from human studies is compatible with a selective, competitive antagonism of histamine H 2 -receptors by ranitidine in humans. Oral or intravenous administration of ranitidine inhibits both basal gastric secretions and gastric acid secretion induced by histamine, pentagastrin and other secretagogues. On a weight basis ranitidine is between 4 and 9 times more potent than cimetidine. After oral administration of ranitidine, the plasma concentrations of ranitidine achieved are directly related to the dose adm Lesen Sie das vollständige Dokument